GC Wealth Management RIA LLC Sells 2,667 Shares of Cigna Group $CI

GC Wealth Management RIA LLC lowered its stake in shares of Cigna Group (NYSE:CI) by 69.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,186 shares of the health services provider’s stock after selling 2,667 shares during the quarter. GC Wealth Management RIA LLC’s holdings in Cigna Group were worth $326,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Capital Research Global Investors boosted its position in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after purchasing an additional 903,334 shares during the period. Ameriprise Financial Inc. boosted its position in Cigna Group by 54.5% during the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after purchasing an additional 753,865 shares during the period. M&T Bank Corp boosted its position in Cigna Group by 1,299.3% during the fourth quarter. M&T Bank Corp now owns 635,706 shares of the health services provider’s stock worth $174,965,000 after purchasing an additional 590,277 shares during the period. Finally, Vanguard Group Inc. boosted its position in Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after purchasing an additional 414,834 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CI shares. Piper Sandler cut their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Leerink Partners increased their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. UBS Group reiterated a “buy” rating and set a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Jefferies Financial Group cut their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Finally, Cantor Fitzgerald increased their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $336.20.

Cigna Group Trading Down 2.6%

Shares of Cigna Group stock opened at $283.14 on Friday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a market cap of $74.62 billion, a price-to-earnings ratio of 12.77, a PEG ratio of 1.01 and a beta of 0.26. The company has a current ratio of 0.73, a quick ratio of 0.74 and a debt-to-equity ratio of 0.69. The company’s 50-day moving average price is $274.34 and its 200-day moving average price is $276.94.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the firm posted $6.74 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts expect that Cigna Group will post 30.35 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 28.13%.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.